Pinnacle Medicines | $89,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
Mirage | $75,000,000 | (Mar 27, 2026)
Certified by Founder
Lodge
Zenerate
start up
United States
- Los Angeles, California
- 11/02/2022
- Pre Series A
- Undisclosed Amount
Zenerate™ is an AI-powered property development tool that pairs feasible building design with market-based profit metrics.
Zenerate designs for commercial, multifamily, and mixed use building types.
Projects that have used our tool have seen a 26% increase to their ROI.
Request a free demo @ www.zenerate.ai
- Industry Architecture & Planning
- Website https://www.zenerate.ai/
- LinkedIn https://www.linkedin.com/company/zenerate/
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)
Payy | $6,000,000 | (Mar 27, 2026)
Conntour | $7,000,000 | (Mar 27, 2026)
KilgourMD | Undisclosed Amount | (Mar 27, 2026)
Terrestrial | $50,000,000 | (Mar 27, 2026)
Krane | $9,000,000 | (Mar 26, 2026)
Zalos (YC F25) | $3,600,000 | (Mar 26, 2026)